• Washington DC |
  • New York |
  • Toronto |
  • Distribution: (800) 510 9863
Saturday, November 21, 2026
  • Login
No Result
View All Result
NEWSLETTER
New Edge Times
  • World
  • U.S.
  • Politics
  • Business
  • Science
  • Tech
  • Youth
  • Entertainment
    • All
    • Arts
    • Gaming
    • Movie
    • Music
    Review: Asmik Grigorian Stars in a New Met Opera ‘Jenufa’

    Review: Asmik Grigorian Stars in a New Met Opera ‘Jenufa’

    ‘The Hunger Games: Sunrise on the Reaping’ Review: Another Tribute

    ‘The Hunger Games: Sunrise on the Reaping’ Review: Another Tribute

    Video: Will A.I. Make This Tedious Hollywood Job Easier?

    Video: Will A.I. Make This Tedious Hollywood Job Easier?

    Anne Teresa De Keersmaeker Comes Full Circle, Spinning to Philip Glass

    Anne Teresa De Keersmaeker Comes Full Circle, Spinning to Philip Glass

    After ‘Boston,’ Where Does Stella Lefty Go?

    After ‘Boston,’ Where Does Stella Lefty Go?

    ‘The Fantasticks’ Review: A Gender Swap for a Still-Tender Story

    ‘The Fantasticks’ Review: A Gender Swap for a Still-Tender Story

    5 Takeaways From the 2027 Grammy Nominations.

    5 Takeaways From the 2027 Grammy Nominations.

    Why Robert Pattinson Could Be a Great James Bond

    Why Robert Pattinson Could Be a Great James Bond

    • Gaming
    • Movie
    • Music
    • Arts
  • Sports
  • Lifestyle
    • All
    • Fashion
    • Food
    • Health
    • Travel
    Street Style Look of the Week: ‘Old Man’ Style and ‘Subliminal Messaging’

    Street Style Look of the Week: ‘Old Man’ Style and ‘Subliminal Messaging’

    And Now, Melissa Clark’s Mashed Potatoes

    And Now, Melissa Clark’s Mashed Potatoes

    Restaurant Review: At Faux, the Scene-y NYC Bistro Enters Its Next Generation

    Restaurant Review: At Faux, the Scene-y NYC Bistro Enters Its Next Generation

    Jessica Craig-Martin Is Thrilled to Decline an Invitation

    Jessica Craig-Martin Is Thrilled to Decline an Invitation

    How the Measles Virus Makes Your Immune System Forget

    How the Measles Virus Makes Your Immune System Forget

    Fearing Chinese Rivals, U.S. Biotech Adopts a New Norm: Share Nothing

    Fearing Chinese Rivals, U.S. Biotech Adopts a New Norm: Share Nothing

    A Hot Springs Road Trip in Southern California

    A Hot Springs Road Trip in Southern California

    Pilots Kept Contact With Controllers During Nationwide Halt to Flights

    Pilots Kept Contact With Controllers During Nationwide Halt to Flights

    • Fashion
    • Food
    • Health
    • Travel
  • Reviews
  • Trending
  • World
  • U.S.
  • Politics
  • Business
  • Science
  • Tech
  • Youth
  • Entertainment
    • All
    • Arts
    • Gaming
    • Movie
    • Music
    Review: Asmik Grigorian Stars in a New Met Opera ‘Jenufa’

    Review: Asmik Grigorian Stars in a New Met Opera ‘Jenufa’

    ‘The Hunger Games: Sunrise on the Reaping’ Review: Another Tribute

    ‘The Hunger Games: Sunrise on the Reaping’ Review: Another Tribute

    Video: Will A.I. Make This Tedious Hollywood Job Easier?

    Video: Will A.I. Make This Tedious Hollywood Job Easier?

    Anne Teresa De Keersmaeker Comes Full Circle, Spinning to Philip Glass

    Anne Teresa De Keersmaeker Comes Full Circle, Spinning to Philip Glass

    After ‘Boston,’ Where Does Stella Lefty Go?

    After ‘Boston,’ Where Does Stella Lefty Go?

    ‘The Fantasticks’ Review: A Gender Swap for a Still-Tender Story

    ‘The Fantasticks’ Review: A Gender Swap for a Still-Tender Story

    5 Takeaways From the 2027 Grammy Nominations.

    5 Takeaways From the 2027 Grammy Nominations.

    Why Robert Pattinson Could Be a Great James Bond

    Why Robert Pattinson Could Be a Great James Bond

    • Gaming
    • Movie
    • Music
    • Arts
  • Sports
  • Lifestyle
    • All
    • Fashion
    • Food
    • Health
    • Travel
    Street Style Look of the Week: ‘Old Man’ Style and ‘Subliminal Messaging’

    Street Style Look of the Week: ‘Old Man’ Style and ‘Subliminal Messaging’

    And Now, Melissa Clark’s Mashed Potatoes

    And Now, Melissa Clark’s Mashed Potatoes

    Restaurant Review: At Faux, the Scene-y NYC Bistro Enters Its Next Generation

    Restaurant Review: At Faux, the Scene-y NYC Bistro Enters Its Next Generation

    Jessica Craig-Martin Is Thrilled to Decline an Invitation

    Jessica Craig-Martin Is Thrilled to Decline an Invitation

    How the Measles Virus Makes Your Immune System Forget

    How the Measles Virus Makes Your Immune System Forget

    Fearing Chinese Rivals, U.S. Biotech Adopts a New Norm: Share Nothing

    Fearing Chinese Rivals, U.S. Biotech Adopts a New Norm: Share Nothing

    A Hot Springs Road Trip in Southern California

    A Hot Springs Road Trip in Southern California

    Pilots Kept Contact With Controllers During Nationwide Halt to Flights

    Pilots Kept Contact With Controllers During Nationwide Halt to Flights

    • Fashion
    • Food
    • Health
    • Travel
  • Reviews
  • Trending
No Result
View All Result
New Edge Times
No Result
View All Result
Home Lifestyle Health

Powerful Psychedelic Gains Renewed Attention as a Treatment for Opioid Addiction

by New Edge Times Report
March 5, 2024
in Health
Powerful Psychedelic Gains Renewed Attention as a Treatment for Opioid Addiction
Share on FacebookShare on Twitter

The drug company Atai Life Sciences is spending millions to research the compound, and congressional lawmakers from both parties have been pushing the government to promote ibogaine research for substance abuse, post-traumatic stress disorder and other mental health problems.

For Dr. Deborah Mash, a professor of neurology at the University of Miami who began studying ibogaine in the early 1990s, the soaring interest is a vindication of her belief that the compound could help ameliorate the opioid crisis. “Ibogaine is not a silver bullet, and it won’t work for everybody, but it’s the most powerful addiction interrupter I’ve ever seen,” she said.

Researchers have also been studying ibogaine’s ability to treat other difficult mental health problems. A small study published earlier this year in the journal Nature Medicine found that military veterans with traumatic brain injuries who underwent a single ibogaine therapy session experienced marked improvements in disability, psychiatric symptoms and cognition.

No adverse side effects were reported among the study’s 30 participants, who were followed for a month. There was no control group.

Dr. Nolan Williams, the study’s lead author, said the results were especially notable given the lack of therapeutic options for traumatic brain injuries.

“These are the most dramatic drug effects I’ve ever captured in an observational study,” said Dr. Williams, who is the director of the Brain Stimulation Lab at Stanford University.

He and other researchers are quick to acknowledge the limitations of existing science on ibogaine therapy. “Without a greenlight to conduct studies from the F.D.A., you just can’t do the kind of randomized trials that are the gold standard for clinical studies,” Dr. Williams said.

Ibogaine is known to induce arrhythmia, or an irregular heartbeat, which in severe cases can lead to fatal cardiac arrest.

Other researchers are more skeptical of its potential as a broadly accessible anti-addiction therapy. William Stoops, a professor of behavioral science at the University of Kentucky who specializes in substance use disorders, said ibogaine’s cardiac risks made it a poor candidate for regulatory consideration.

Even if ibogaine were to receive approval from the Food and Drug Administration, the tattered health of many long-term opioid users, many of whom have cardiovascular problems, would make them ineligible for treatment, Dr. Stoops said. And the high cost of providing ibogaine in a medically supervised setting would further reduce the pool of potential patients, he added. “Access would be so restricted that how many people could benefit?” he asked.

The National Institute on Drug Abuse, part of the National Institutes of Health, has already begun funding studies (that are not trials involving humans) on ibogaine analogues, chemically related compounds that might provide the therapeutic benefits without the health risks. The agency’s director, Dr. Nora Volkow, said she had long been intrigued by ibogaine’s anti-addiction potential — and wary of its cardiac risks.

But existing treatments for opioid use disorder, like methadone and buprenorphine, are imperfect, she noted, and half of all patients stop taking them after six months

“In addition to existing effective medications, there is a need for treatment options that are different from the ones we currently have,” Dr. Volkow said. “We need to break the way we have been doing things and explore what the science is showing us.”

The F.D.A. said it could not comment on whether it would support ibogaine studies in the future, noting that federal law prohibits the agency from commenting on prospective investigational drug applications.

Previous Post

What to Know About Ibogaine

Next Post

Just Try to Find Women in Horology History

Related Posts

How the Measles Virus Makes Your Immune System Forget
Health

How the Measles Virus Makes Your Immune System Forget

by New Edge Times Report
November 17, 2026
Fearing Chinese Rivals, U.S. Biotech Adopts a New Norm: Share Nothing
Health

Fearing Chinese Rivals, U.S. Biotech Adopts a New Norm: Share Nothing

by New Edge Times Report
November 17, 2026
An Intriguing Approach to Slow Alzheimer’s Shows Mixed Results
Health

An Intriguing Approach to Slow Alzheimer’s Shows Mixed Results

by New Edge Times Report
November 16, 2026
Leave Comment
New Edge Times

© 2025 New Edge Times or its affiliated companies. All rights reserved.

Navigate Site

  • About
  • Advertise
  • Terms & Conditions
  • Privacy Policy
  • Disclaimer
  • Contact

Follow Us

No Result
View All Result
  • World
  • U.S.
  • Politics
  • Business
  • Science
  • Tech
  • Youth
  • Entertainment
    • Gaming
    • Movie
    • Music
    • Arts
  • Sports
  • Lifestyle
    • Fashion
    • Food
    • Health
    • Travel
  • Reviews
  • Trending

© 2025 New Edge Times or its affiliated companies. All rights reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In